Our artificial heart
Start of phase 1 pre-clinical trials
We’re testing a first version of the prosthesis on animals, which will have the dimensions and performance levels of the final prosthesis. Only the materials used will not be definitive (not biocompatible).
in 2024, here are the targets we have set ourselves.
The advantages of our prothesis
Procope Medicals is developing an artificial heart combining a number of technical innovations, enabling the device to be fully implantable and adapted to the widest possible range of morphologies. We are working to considerably improve patients’ autonomy, and consequently their comfort of life.
“The total artificial heart we are developing will considerably improve patient autonomy, and will then make it available to the greatest number of women and men waiting for solutions.”
CEO - Scientific Director
Would you like to take part in a global health project ?
The development plan to follow
Validation phase: experimental, numerical and anatomical validation
Acquisition of intellectual property
Functional version of the prosthesis
Pre-clinical studies: POC blood tests
and animal testing
Biocompatible, self-regulating preclinical version of the prosthesis
Clinical trials : human trials
Clinical version of the prosthesis with implantable battery and remote monitoring system
Market launch : CE marking and
BTT IDE study